Biolase reported a 46% increase in its third-quarter revenue (end-September 30, 2021).
The company's revenue increased from $6.5 million for the period in 2020 to $9.5 million for the same period this year. The company attributed the increase to the effect of COVID-19 in 2020.
For the nine months ending September 30, the company's revenue was $26.8 million, compared with $14.3 million in 2020.